Medexus Pharma Inc.
Chicago, IL
- UEI
- M7B3Y5ZKMK35
- CAGE
- 78FA0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 29 N Upper Wacker Dr #704, Chicago, IL 60606, USA
- Website
- medexus.com
- Founded
- 2012
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Medexus pharma INC:1366043 [23-003118] gleolan | NIH Clinical Center | $12,412 | |
| Medexus pharma INC:1366043 [23-001274] gleolan | NIH Clinical Center | $12,052 |
About Medexus Pharma Inc.
Medexus Pharma Inc. is a leading North American specialty pharmaceutical company focused on hematology, rheumatology, autoimmune disease, specialty oncology, and pediatrics. It provides pharmaceutical and drug products to the federal government through contract awards.
Through prime federal contract awards, Medexus Pharma Inc. has provided the drug GLEOLAN to the Department of Health and Human Services National Institutes of Health Clinical Center. The contracts were for purchase orders with potential values around $12,000 each and completion dates in 2023 and 2024. No set-asides were used for these awards.
Medexus Pharma Inc. holds a Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 for pharmaceuticals and drugs under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. This multiple-award IDV, with a potential value of $12 million and a period of performance through September 2025, aims to procure various drugs, pharmaceuticals, and hematology-related products for VA medical facilities to support treatment of veterans through the VA healthcare system. No set-aside provisions were used in the award to Medexus Pharma.
Contract vehicles
Quick answers
What is Medexus Pharma Inc.'s UEI?
Medexus Pharma Inc.'s Unique Entity ID (UEI) in SAM.gov is M7B3Y5ZKMK35.
What is Medexus Pharma Inc.'s CAGE code?
Medexus Pharma Inc.'s CAGE code is 78FA0.
What is Medexus Pharma Inc.'s primary NAICS code?
Medexus Pharma Inc.'s primary NAICS code is 424210 (Drugs and Druggists' Sundries Merchant Wholesalers).
Where is Medexus Pharma Inc. located?
Medexus Pharma Inc.'s physical address in SAM.gov is 29 N Upper Wacker Dr #704, Chicago, IL 60606, USA.
Is Medexus Pharma Inc. registered in SAM.gov?
Yes. Medexus Pharma Inc.'s SAM.gov registration is active through September 4, 2027.
Which contract vehicles does Medexus Pharma Inc. hold?
Medexus Pharma Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Medexus Pharma Inc.'s most recent federal award?
Medexus Pharma Inc.'s most recent federal contract award is Medexus pharma INC:1366043 [23-003118] gleolan (75N90023P00153), from NIH Clinical Center, on January 25, 2023.
On GovTribe
See Medexus Pharma Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors